Reply to: "COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution"

Affiliations

¹ Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mt Sinai Hospital, New York, New York.
² Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mt Sinai Hospital, New York, New York. Electronic address: ryan.riveraoyola@mountsinai.org.
³ Department of Dermatology, St. George Hospital, University of New South Wales, Sydney, Australia.

Comment

Mark Lebwohl et al. J Am Acad Dermatol. 2020 Jun.

. 2020 Jun;82(6):e215.

doi: 10.1016/j.jaad.2020.03.103. Epub 2020 Apr 10.

¹ Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mt Sinai Hospital, New York, New York.
² Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mt Sinai Hospital, New York, New York. Electronic address: ryan.riveraoyola@mountsinai.org.
³ Department of Dermatology, St. George Hospital, University of New South Wales, Sydney, Australia.

No abstract available

Comment on

COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution.
Kansal NK. Kansal NK. J Am Acad Dermatol. 2020 Jun;82(6):e213. doi: 10.1016/j.jaad.2020.03.079. Epub 2020 Apr 1. J Am Acad Dermatol. 2020. PMID: 32246966 Free PMC article. No abstract available.

1. Kansal N.K. COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: a word of caution. J Am Acad Dermatol. 2020;82:e213. - PMC - PubMed
1. Lebwohl M., Rivera-Oyola R., Murrell D.F. Should biologics for psoriasis be interrupted in the era of COVID-19? J Am Acad Dermatol. 2020;82(5):1217–1218. - PMC - PubMed
1. Puel A., Cypowyj S., Marodi L., Abel L., Picard C., Casanova J.L. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol. 2012;12(6):616–622. - PMC - PubMed
1. Altare F., Jouanguy E., Lamhamedi S., Doffinger R., Fischer A., Casanova J.L. Mendelian susceptibility to mycobacterial infection in man. Curr Opin Immunol. 1998;10(4):413–417. - PubMed
1. Conti P., Ronconi G., Caraffa A., et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34(2) - PubMed